Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study)
Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
This study will examine the use of the dexamethasone implant (Ozurdex) in patients with
macular edema associated with an epiretinal or preretinal membrane requiring surgical
intervention. After the surgery is performed (pars plana vitrectomy), an Ozurdex implant will
be placed in the eye. Patients will be followed for 1 year.